We believe our ability to create more robust and controlled insulin producing cell transplants that can be monitored in vivo over time will revolutionize the current clinical landscape for diabetes and cell replacement therapy.
Latest News
Aug 31, 2023
Minutia Featured in California Institute for Regenerative Medicine (CIRM) Annual Report
Read More
June 26, 2023
Minutia, Oregon Health & Sciences University and Go Pen Win First-Ever American Diabetes Association Innovation Challenge
Read More
May 22, 2023
Minutia receives award from JDRF to further develop real-time monitoring platform for cell therapies
Read More
Minutia's Science is Supported by these Non-dilutive Funders